
Maurice Perol, MD, discusses the persistent unmet need for effective treatments following progression on immunotherapy in NSCLC.

Your AI-Trained Oncology Knowledge Connection!


Maurice Perol, MD, discusses the persistent unmet need for effective treatments following progression on immunotherapy in NSCLC.










Published: October 16th 2025 | Updated:

Published: October 20th 2020 | Updated:

Published: October 20th 2020 | Updated:

Published: October 20th 2020 | Updated:

Published: October 20th 2020 | Updated:

Published: October 20th 2020 | Updated: